A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Sponsors and Collaborators
Astellas Pharma Inc

Contact
Clinical Development Administration Dept.
[email protected]

Principal Investigator
Medical Director, Astellas Pharma Inc


Continue Reading

ClinicalTrials.gov Identifier
NCT01742585